David R. Hassman, DOJuly 18, 2014

FDA 483 - David R. Hassman, DO - July 18, 2014

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore David R. Hassman, DO

Record Details

An FDA inspection of David R. Hassman, D. O., Principal Investigator, in Berlin, NJ, identified a significant deviation from the investigational plan. The firm failed to conduct the study in accordance with the protocol, specifically regarding the timing of audiology assessments and various study visits. This non-compliance impacts the integrity of the clinical trial data for Protocols HYD3002 and HYD3003.

Company: David R. Hassman, DO
Inspection Date: July 18, 2014
Product Type: Drugs
Office: New Jersey District Office
Person: Loretta Nemchik

Open in Dashboard

ID · 84a07a88-449a-4909-9db7-4cc57edd2a74